Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells

J Alzheimers Dis. 2007 Nov;12(3):223-8. doi: 10.3233/jad-2007-12303.

Abstract

In this study we analysed the effect of Bcl-2 on the cytotoxicity induced by the amyloid-beta (Abeta(25-35)) and prion (PrP(106-126)) peptides by using GT1-7puro and GT1-7bcl-2 (overexpressing the anti-apoptotic protein Bcl-2) neural cells. Exposure to Abeta(25-35) (1-5 microM) and PrP(106-126) (25 microM) caused a decrease in cell viability, as determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. These data were correlated with Abeta(25-35) and PrP(106-126)-induced activation of caspase-9, which is linked to the mitochondrial death pathway, and the activation of the effector caspase-3, suggesting cell death by apoptosis. Furthermore, Bcl-2 overexpression protected from loss of cell viability and caspase-9 and -3 activation induced by Abeta(25-35) and PrP(106-126), showing that Bcl-2 is neuroprotective against apoptotic cell death caused by amyloidogenic peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Amyloid beta-Protein Precursor / genetics*
  • Amyloid beta-Protein Precursor / metabolism*
  • Caspase 3
  • Caspase 9
  • Genes, bcl-2 / genetics*
  • Humans
  • Hypothalamus / metabolism
  • Hypothalamus / pathology
  • Myosin Light Chains
  • Neurons / metabolism*
  • Neurons / pathology
  • Prions* / genetics
  • Prions* / metabolism
  • Prions* / toxicity
  • Proteins / genetics*
  • Proteins / metabolism*

Substances

  • Amyloid beta-Protein Precursor
  • MYL4 protein, human
  • Myosin Light Chains
  • Prions
  • Proteins
  • Caspase 3
  • Caspase 9